Max S Topp Selected Research

blinatumomab

1/2021	Blinatumomab as first salvage versus second or later salvage in adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemia: Results of a pooled analysis.
1/2021	Long-term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab.
11/2020	Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia.
1/2020	Blinatumomab consolidation and maintenance therapy in adults with relapsed/refractory B-precursor acute lymphoblastic leukemia.
12/2019	Transplantation in adults with relapsed/refractory acute lymphoblastic leukemia who are treated with blinatumomab from a phase 3 study.
10/2019	Molecular response with blinatumomab in relapsed/refractory B-cell precursor acute lymphoblastic leukemia.
1/2019	Neurologic adverse events in patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab: management and mitigating factors.
1/2019	Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemia.
1/2019	Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
10/2018	Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Max S Topp Research Topics

Disease

27	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 02/2003
16	Hodgkin Disease (Hodgkin's Disease) 10/2022 - 02/2010
16	Neoplasms (Cancer) 05/2022 - 02/2003
14	Residual Neoplasm 06/2022 - 02/2003
9	Multiple Myeloma 10/2021 - 03/2009
9	Philadelphia Chromosome 01/2021 - 12/2012
8	Infections 01/2021 - 02/2007
7	Leukemia 01/2019 - 02/2003
6	Cytokine Release Syndrome 11/2021 - 12/2015
5	Bites and Stings (Sting) 01/2021 - 06/2012
5	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019 - 09/2009
4	Lymphoma (Lymphomas) 01/2022 - 01/2019
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 02/2022 - 01/2020
3	Hematologic Neoplasms (Hematological Malignancy) 05/2021 - 09/2009
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 06/2022 - 01/2020
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2022 - 04/2016
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2022 - 10/2015
2	B-Cell Lymphoma (Lymphoma, B Cell) 11/2021 - 01/2019
2	Anemia 05/2021 - 05/2010
2	Body Weight (Weight, Body) 01/2020 - 06/2015
2	Seizures (Absence Seizure) 01/2017 - 10/2016
2	Aspergillosis 04/2015 - 03/2006
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2021
1	Hemolytic Anemia 05/2021
1	Pancytopenia 05/2021
1	Deglutition Disorders (Dysphagia) 01/2021
1	Monosomy 01/2021
1	Mucositis 01/2021
1	Febrile Neutropenia 01/2021
1	Disease Progression 01/2020
1	Cytopenia 10/2018
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2018
1	Mucormycosis 01/2017
1	Acute Biphenotypic Leukemia (Leukemia, Mixed Cell) 01/2017
1	Nausea 04/2015

Drug/Important Bio-Agent (IBA)

28	blinatumomabIBA 01/2021 - 06/2011
9	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2021 - 04/2009
6	Bleomycin (Blenoxane)FDA LinkGeneric 06/2021 - 03/2012
5	Prednisone (Sone)FDA LinkGeneric 06/2021 - 10/2015
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2021 - 10/2015
5	Dacarbazine (DIC)FDA LinkGeneric 04/2021 - 03/2012
4	Chimeric Antigen ReceptorsIBA 06/2022 - 01/2020
4	Rituximab (Mabthera)FDA Link 02/2022 - 10/2015
4	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 04/2009
4	Procarbazine (Matulane)FDA Link 06/2021 - 12/2017
4	Vincristine (Oncovin)FDA LinkGeneric 06/2021 - 10/2015
4	Etoposide (VP 16)FDA LinkGeneric 06/2021 - 12/2017
4	Vinblastine (Vinblastine Sulfate)FDA Link 04/2021 - 03/2012
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2015 - 09/2009
3	Antiviral Agents (Antivirals)IBA 12/2015 - 02/2007
2	brexucabtagene autoleucelIBA 06/2022 - 01/2020
2	obinutuzumabIBA 02/2022 - 01/2020
2	Brentuximab VedotinIBA 01/2022 - 12/2017
2	tocilizumab (atlizumab)FDA Link 11/2021 - 11/2021
2	B-Cell Maturation AntigenIBA 01/2021 - 10/2020
2	Bispecific AntibodiesIBA 01/2019 - 01/2019
2	Pharmaceutical PreparationsIBA 12/2017 - 04/2015
2	Monoclonal AntibodiesIBA 01/2017 - 03/2009
2	AntigensIBA 04/2015 - 07/2011
2	Proteins (Proteins, Gene)FDA Link 03/2015 - 06/2011
2	Immunoglobulin M (IgM)IBA 03/2015 - 01/2013
2	AntibodiesIBA 06/2011 - 02/2007
2	Lenalidomide (CC 5013)FDA Link 02/2010 - 04/2009
2	Interleukin-2 (IL2)IBA 11/2006 - 09/2003
1	ibrutinibIBA 10/2022
1	atezolizumabIBA 02/2022
1	polatuzumab vedotinIBA 02/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	Carmustine (FIVB)FDA Link 01/2022
1	Everolimus FDA Link 01/2022
1	insulin receptor-related receptor (IRR)IBA 11/2021
1	axicabtagene ciloleucelIBA 11/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2021
1	Bendamustine Hydrochloride FDA Link 12/2020
1	venetoclaxIBA 12/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2018
1	Immunoconjugates (Immunoconjugate)IBA 12/2017
1	Tyrosine Kinase InhibitorsIBA 06/2017
1	CI 22IBA 06/2017
1	Polo-Like Kinase 1IBA 01/2016
1	Protein Isoforms (Isoforms)IBA 12/2015
1	Bortezomib (Velcade)FDA Link 10/2015
1	AFM13IBA 06/2015

Therapy/Procedure

20	Therapeutics 05/2022 - 09/2009
19	Drug Therapy (Chemotherapy) 01/2022 - 12/2009
9	Immunotherapy 11/2021 - 08/2009
8	Stem Cell Transplantation 12/2019 - 03/2006
7	Hematopoietic Stem Cell Transplantation 01/2019 - 02/2003
3	Aftercare (After-Treatment) 05/2021 - 01/2018
3	Radiotherapy 01/2021 - 03/2012
2	Salvage Therapy 12/2019 - 01/2015
2	Transplantation 12/2019 - 12/2016
1	Drug Tapering 11/2021
1	Complementary Therapies (Alternative Medicine) 01/2019
1	Haploidentical Transplantation 01/2019
1	Combination Drug Therapy (Combination Chemotherapy) 12/2017